These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7650688)

  • 1. The histamine H1-receptor antagonist binding site. A stereoselective pharmacophoric model based upon (semi-)rigid H1-antagonists and including a known interaction site on the receptor.
    ter Laak AM; Venhorst J; Donné-Op den Kelder GM; Timmerman H
    J Med Chem; 1995 Aug; 38(17):3351-60. PubMed ID: 7650688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histamine H1-receptor antagonist binding site. Part I: Active conformation of cyproheptadine.
    van Drooge MJ; Donné-op den Kelder GM; Timmerman H
    J Comput Aided Mol Des; 1991 Aug; 5(4):357-70. PubMed ID: 1686618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling and mutation studies on the histamine H1-receptor agonist binding site reveal different binding modes for H1-agonists: Asp116 (TM3) has a constitutive role in receptor stimulation.
    ter Laak AM; Timmerman H; Leurs R; Nederkoorn PH; Smit MJ; Donné-Op den Kelder GM
    J Comput Aided Mol Des; 1995 Aug; 9(4):319-30. PubMed ID: 8523041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the antagonist-binding site of the histamine H(1) receptor.
    Wieland K; Laak AM; Smit MJ; Kühne R; Timmerman H; Leurs R
    J Biol Chem; 1999 Oct; 274(42):29994-30000. PubMed ID: 10514483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative structure-activity relationships of benztropine analogues at the dopamine transporter and histamine H(1) receptors.
    Kulkarni SS; Kopajtic TA; Katz JL; Newman AH
    Bioorg Med Chem; 2006 Jun; 14(11):3625-34. PubMed ID: 16460947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineation of receptor-ligand interactions at the human histamine H1 receptor by a combined approach of site-directed mutagenesis and computational techniques - or - how to bind the H1 receptor.
    Jongejan A; Leurs R
    Arch Pharm (Weinheim); 2005 Jun; 338(5-6):248-59. PubMed ID: 15952243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents].
    Differding E; Gillard M; Moguilevsky N; Varsalona F; Noyer M; Daliers J; Goldstein S; Neuwels M; Lassoie MA; Guillaume JP; Bascour M; Bollen A; Hénichart JP
    J Pharm Belg; 1996; 51(3):155-60. PubMed ID: 8778348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of histamine H1-receptor antagonists derived from the cimetidine group of histamine H2-receptor antagonists.
    Bannister C; Burns K; Prout K; Watkin DJ; Cooper DG; Duránt GJ; Ganellin CR; Ife RJ; Sach GS
    Acta Crystallogr B; 1994 Apr; 50 ( Pt 2)():221-43. PubMed ID: 7911673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico binding characteristics between human histamine H1 receptor and antagonists.
    Wang X; Yang Q; Li M; Yin D; You Q
    J Mol Model; 2010 Sep; 16(9):1529-37. PubMed ID: 20179978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Analysis of the Histamine H
    Shiroishi M; Kobayashi T
    Handb Exp Pharmacol; 2017; 241():21-30. PubMed ID: 27826702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-dependent complexation of histamine H1 receptor antagonists and human serum albumin studied by UV resonance Raman spectroscopy.
    Tardioli S; Buijs J; Gooijer C; van der Zwan G
    J Phys Chem B; 2012 Mar; 116(12):3808-15. PubMed ID: 22372713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of antihistamines on the function of human α7-nicotinic acetylcholine receptors.
    Sadek B; Khanian SS; Ashoor A; Prytkova T; Ghattas MA; Atatreh N; Nurulain SM; Yang KH; Howarth FC; Oz M
    Eur J Pharmacol; 2015 Jan; 746():308-16. PubMed ID: 25445036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical studies on the histamine H2 receptor: molecular mechanism of action of antagonists.
    Giraldo J; Martín M; Campillo M; Pardo L
    Mol Pharmacol; 1992 Aug; 42(2):373-81. PubMed ID: 1355265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
    Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
    Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
    Hishinuma S; Young JM
    Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique binding pocket for KW-4679 in the histamine H1 receptor.
    Nonaka H; Otaki S; Ohshima E; Kono M; Kase H; Ohta K; Fukui H; Ichimura M
    Eur J Pharmacol; 1998 Mar; 345(1):111-7. PubMed ID: 9593602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
    Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
    Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.